Global Phase I START operates a largest Phase I cancer trial program with a global network in San Antonio, Madrid, and Shanghai, presenting an opportunity to partner for cross-border early-phase studies and access to diverse patient populations.

Small to Mid With 11-50 employees and a focused clinical trial operations team, START can be a cost-effective partner for centralized Phase I execution, site management, and rapid study start-up for oncology programs seeking nimble collaborators.

Access to Patients Aligned mission to accelerate anticancer drug development and improve patient outcomes suggests strong enthusiasm for early-phase collaboration, enabling sponsors to leverage START’s established networks to reach end-stage cancer patients screening opportunities.

Digital Presence Existing tech stack including WordPress, SEO, analytics, and lightweight web tools indicates readiness for digital outreach, study recruitment marketing, and partner integration portals to streamline inquiries and site activation.

Funding Signals Reported revenue range (one to several millions) points to a growing but lean organization, presenting potential for co-development, sponsored research agreements, and value-based partnerships that align with START’s expansion and capacity-building goals.